Analysis conducted on the GEPIA portal (http://gepia.cancer-pku.cn accessed 5 July 2023) indicates that higher CCR6 expression in AML cells is associated with a worse prognosis for patients [27]. This evidence concerns the gene CCR6 and acute myeloid leukemia.